Raburn M. Mallory

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Reporting the Recruitment Process in Clinical Trials: Who Are These Patients and How Did They Get There?

Cary P. Gross, Raburn M. Mallory, Asefeh Heiat et al. · Annals of Internal Medicine · 2002 · 196 citations

Public Health, Population Health Sciences, Clinical Epidemiology +16

The role of nasal IgA in children vaccinated with live attenuated influenza vaccine

Christopher S. Ambrose, Xionghua Wu, Taff Jones et al. · Vaccine · 2012 · 116 citations · Full text

Medicine, Immunology, Pediatrics +17

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial

Neil Formica, Raburn M. Mallory, Gary Albert et al. · PLoS Medicine · 2021 · 113 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease.

Sudhir Sekhsaria, John I. Gallin, G F Linton et al. · Proceedings of the National Academy of Sciences · 1993 · 81 citations

Life Sciences, Genetics, Hematology +16